keyword
Keywords Killer immunoglobulin like rec...

Killer immunoglobulin like receptors

https://read.qxmd.com/read/38328160/full-resolution-hla-and-kir-genes-annotation-for-human-genome-assemblies
#21
Ying Zhou, Li Song, Heng Li
The HLA (Human Leukocyte Antigen) genes and the KIR (Killer cell Immunoglobulin-like Receptor) genes are critical to immune responses and are associated with many immune-related diseases. Located in highly polymorphic regions, they are hard to be studied with traditional short-read alignment-based methods. Although modern long-read assemblers can often assemble these genes, using existing tools to annotate HLA and KIR genes in these assemblies remains a non-trivial task. Here, we describe Immuannot, a new computation tool to annotate the gene structures of HLA and KIR genes and to type the allele of each gene...
January 23, 2024: bioRxiv
https://read.qxmd.com/read/38290769/combination-of-oligo-fractionated-irradiation-with-nivolumab-can-induce-immune-modulation-in-gastric-cancer
#22
JOURNAL ARTICLE
Kosaku Mimura, Takashi Ogata, Phuong H D Nguyen, Souvick Roy, Hassen Kared, Yate-Ching Yuan, Michael Fehlings, Yuya Yoshimoto, Daisaku Yoshida, Shotaro Nakajima, Hisashi Sato, Nozomu Machida, Takanobu Yamada, Yohei Watanabe, Tomoaki Tamaki, Hirohito Fujikawa, Yasuhiro Inokuchi, Suguru Hayase, Hiroyuki Hanayama, Zenichiro Saze, Hiroyuki Katoh, Fumiaki Takahashi, Takashi Oshima, Ajay Goel, Alessandra Nardin, Yoshiyuki Suzuki, Koji Kono
BACKGROUND: Tumor-associated antigen (TAA)-specific CD8(+) T cells are essential for nivolumab therapy, and irradiation has been reported to have the potential to generate and activate TAA-specific CD8(+) T cells. However, mechanistic insights of T-cell response during combinatorial immunotherapy using radiotherapy and nivolumab are still largely unknown. METHODS: Twenty patients included in this study were registered in the CIRCUIT trial (ClinicalTrials.gov, NCT03453164)...
January 30, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38289706/essential-role-of-cd155-glycosylation-in-functional-binding-to-dnam-1-on-natural-killer-cells
#23
JOURNAL ARTICLE
Saeko Tahara, Genki Okumura, Tomohei Matsuo, Akira Shibuya, Kazuko Shibuya
CD155 is highly expressed on tumor cells and augments or inhibits the cytotoxic activities of natural killer (NK) cells and T cells through its receptor ligands DNAM-1 and T cell immunoglobulin immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), respectively. Although CD155 is heavily glycosylated, the role of glycosylation of CD155 in the cytotoxic activity of effector lymphocytes remains unknown. Here, we show that the N-linked glycosylation at residue 105 (N105 glycosylation) in the first immunoglobulin-like domain of CD155 is involved in the binding of CD155 to both DNAM-1 and TIGIT...
January 30, 2024: International Immunology
https://read.qxmd.com/read/38262874/activating-kir-hla-i-combinations-as-a-risk-factor-of-adult-b-all
#24
JOURNAL ARTICLE
Hossein Halimi, Sara Mirzazadeh, Kurosh Kalantar, Maryam Hajimaghsoodi, Mani Ramzi, Shirin Farjadian
B-cell acute lymphoblastic leukemia (B-ALL), the most predominant type of ALL, is less common and incurable among adults. Regarding the pivotal role of NK cells in immune surveillance against hematological malignancies, studying the effective factors in regulating their function, particularly KIRs as the most important NK cell receptors and HLA-I molecules as their main ligands, is of importance. Since NK responses against malignant lymphoblasts are influenced by KIR signals, we did a case-control study on 154 adult patients with B-ALL and 181 healthy controls to investigate the correlation of KIR/HLA-I combinations with susceptibility to B-ALL in Iranians...
January 22, 2024: Human Immunology
https://read.qxmd.com/read/38229912/targeting-kir-as-a-novel-approach-to-improve-car-nk-cell-function
#25
JOURNAL ARTICLE
Lara V Graham, Jack G Fisher, Salim I Khakoo, Matthew D Blunt
Chimeric antigen receptor (CAR) NK cells are demonstrating promising activity in clinical trials and possess a favorable safety profile compared to CAR-T cells. The Killer cell Immunoglobulin-like Receptors (KIR) have a critical role in the control of NK cell function, and recently, this family of activating and inhibitory receptors have been targeted to improve CAR-NK function. These strategies include the utilisation of inhibitory KIR to reduce trogocytosis-associated NK cell fratricide, the downregulation of inhibitory KIR on CAR-NK cells to alleviate HLA mediated suppression, the selection of CAR-NK cell donors enriched for activating KIR, and the use of activating KIR intracellular domains within novel CAR constructs...
December 5, 2023: Journal of translational genetics and genomics
https://read.qxmd.com/read/38226399/complete-hla-genotyping-of-type-1-diabetes-patients-and-controls-from-mali-reveals-both-expected-and-novel-disease-associations
#26
JOURNAL ARTICLE
Janelle A Noble, Stéphane Besançon, Assa Traore Sidibé, Erik H Rozemuller, Maaike Rijkers, Fereshte Dadkhodaie, Helma de Bruin, Jannetje Kooij, Harper R N Martin, Graham D Ogle, Steven J Mack
HLA genotyping was performed on 99 type 1 diabetes (T1D) patients and 200 controls from Mali. Next-generation sequencing of the classical HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, and -DPB1 loci revealed strong T1D association for all loci except HLA-C and -DPA1. Class II association is stronger than class I association, with most observed associations predisposing or protective as expected based on previous studies. For example, HLA-DRB1*03:01, HLA-DRB1*09:01, and HLA-DRB1*04:05 predispose for T1D, whereas HLA-DRB1*15:03 is protective...
January 2024: HLA
https://read.qxmd.com/read/38206349/determination-for-kir-genotype-and-allele-copy-number-via-real-time-quantitative-pcr-method
#27
JOURNAL ARTICLE
Sudan Tao, Xuan You, Jielin Wang, Wei Zhang, Ji He, Faming Zhu
Killer cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) play crucial roles in regulating NK cell activity. Here, we report a real-time quantitative PCR (qPCR) to genotype all KIR genes and their copy numbers simultaneously. With 18 pairs of locus-specific primers, we identified KIR genes by Ct values and determined KIR copy number using the 2-∆Ct method. Haplotypes were assigned based on KIR gene copy numbers. The real-time qPCR results were consistent with the NGS method, except for one sample with KIR2DL5 discrepancy...
January 11, 2024: Immunogenetics
https://read.qxmd.com/read/38202265/association-of-kir-genes-with-middle-east-respiratory-syndrome-coronavirus-infection-in-south-koreans
#28
JOURNAL ARTICLE
In-Cheol Baek, Eun-Jeong Choi, Hyoung-Jae Kim, Haeyoun Choi, Hyoung-Shik Shin, Dong-Gyun Lim, Tai-Gyu Kim
BACKGROUND: Middle East respiratory syndrome (MERS) is a lower respiratory tract disease caused by a beta coronavirus (CoV) called MERS-CoV, characterized by a high mortality rate. We aimed to evaluate the association between genetic variation in killer cell immunoglobulin-like receptors (KIRs) and the risk of MERS in South Koreans. METHODS: KIR genes were genotyped by multiplex polymerase chain reaction with sequence-specific primers (PCR-SSP). A case-control study was performed to identify the odds ratios (OR) of KIR genes for MERS and the association of KIR genes and their ligands, human leukocyte antigens (HLA) genes...
January 2, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38201263/immunological-aspects-of-infertility-the-role-of-kir-receptors-and-hla-c-antigen
#29
REVIEW
Anna Wasilewska, Marcelina Grabowska, Dominika Moskalik-Kierat, Martyna Brzoza, Piotr Laudański, Marzena Garley
The mechanisms of immune tolerance of a mother against an antigenically foreign fetus without a concomitant loss of defense capabilities against pathogens are the factors underlying the success of a pregnancy. A significant role in human defense is played by killer immunoglobulin-like receptor (KIR) receptors, which regulate the function of the natural killer (NK) cells capable of destroying antigenically foreign cells, virus-infected cells, or tumor-lesioned cells. A special subpopulation of NK cells called uterine NK cells (uNK) is found in the uterus...
December 27, 2023: Cells
https://read.qxmd.com/read/38200592/non-invasive-molecular-biomarkers-for-monitoring-solid-organ-transplantation-a-comprehensive-overview
#30
REVIEW
Jeffy J Fernando, Raja Biswas, Lalitha Biswas
Solid organ transplantation is a life-saving intervention for individuals with end-stage organ failure. Despite the effectiveness of immunosuppressive therapy, the risk of graft rejection persists in all viable transplants between individuals. The risk of rejection may vary depending on the degree of compatibility between the donor and recipient for both human leucocyte antigen (HLA) and non-HLA gene-encoded products. Monitoring the status of the allograft is a critical aspect of post-transplant management, with invasive biopsies being the standard of care for detecting rejection...
January 10, 2024: International Journal of Immunogenetics
https://read.qxmd.com/read/38185735/structural-basis-for-the-activity-and-specificity-of-the-immune-checkpoint-inhibitor-lirilumab
#31
JOURNAL ARTICLE
Nicholas Lorig-Roach, Nina M Harpell, Rebecca M DuBois
The clinical success of immune checkpoint inhibitors has underscored the key role of the immune system in controlling cancer. Current FDA-approved immune checkpoint inhibitors target the regulatory receptor pathways of cytotoxic T-cells to enhance their anticancer responses. Despite an abundance of evidence that natural killer (NK) cells can also mediate potent anticancer activities, there are no FDA-approved inhibitors targeting NK cell specific checkpoint pathways. Lirilumab, the most clinically advanced NK cell checkpoint inhibitor, targets inhibitory killer immunoglobulin-like receptors (KIRs), however it has yet to conclusively demonstrate clinical efficacy...
January 7, 2024: Scientific Reports
https://read.qxmd.com/read/38181855/the-absence-of-seroconversion-after-exposition-to-hepatitis-c-virus-is-not-related-to-kir-hla-genotype-combinations-gehep-012-study
#32
JOURNAL ARTICLE
Carmen Martín-Sierra, María José Bravo, María Eugenia Sáez, Itziar De Rojas, Marta Santos, Jesica Martín-Carmona, Anaïs Corma-Gómez, Alejandro González-Serna, José Luis Royo, Juan A Pineda, Antonio Rivero, Antonio Rivero-Juárez, Juan Macías, Luis Miguel Real
BACKGROUND & AIMS: It has been reported that specific killer-cell immunoglobulin-like receptors (KIRs) and HLA genotype combinations, such as KIR2DS4/HLA-C1 with presence of KIRDL2 or KIRDL3, homozygous KIRDL3/HLA-C1 and KIR3DL1/≥2HLA-Bw4, are strongly associated with the lack of active infection and seroconversion after exposition to hepatitis C virus (HCV). OBJECTIVE: To determine whether these KIR-HLA combinations are relevant factors involved in that phenotype...
January 3, 2024: Antiviral Research
https://read.qxmd.com/read/38180282/high-resolution-characterization-of-kir-genes-polymorphism-in-healthy-subjects-from-the-bulgarian-population-a-pilot-study
#33
JOURNAL ARTICLE
Bushra Al Hadra, Tsvetelin Lukanov, Anastasiya Mihaylova, Elissaveta Naumova
Although killer-cell immunoglobulin-like receptor (KIR) gene content has been widely studied in health and disease, with the advancement of next-generation sequencing (NGS) technology the high-resolution characterization of this complex gene region has become achievable. KIR allele-level diversity has lately been described across human populations. The present study aimed to analyze for the first time the allele-level polymorphism of nine KIR genes in 155 healthy, unrelated individuals from the Bulgarian population by applying NGS...
January 2024: HLA
https://read.qxmd.com/read/38149259/the-kir-repertoire-of-a-west-african-chimpanzee-population-is-characterized-by-limited-gene-allele-and-haplotype-variation
#34
JOURNAL ARTICLE
Natasja G de Groot, Corrine M C Heijmans, Marit K H van der Wiel, Jesse Bruijnesteijn, Ronald E Bontrop
INTRODUCTION: The killer cell immunoglobulin-like receptors (KIR) play a pivotal role in modulating the NK cell responses, for instance, through interaction with major histocompatibility complex (MHC) class I molecules. Both gene systems map to different chromosomes but co-evolved during evolution. The human KIR gene family is characterized by abundant allelic polymorphism and copy number variation. In contrast, our knowledge of the KIR repertoire in chimpanzees is limited to 39 reported alleles, with no available population data...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38097018/natural-killer-cell-functional-genetics-and-donor-specific-antibody-triggered-microvascular-inflammation
#35
JOURNAL ARTICLE
Matthias Diebold, Hannes Vietzen, Andreas Heinzel, Susanne Haindl, Carsten T Herz, Katharina Mayer, Konstantin Doberer, Alexander Kainz, Ingrid Faé, Sabine Wenda, Laura M Kühner, Sarah M Berger, Elisabeth Puchhammer-Stöckl, Nicolas Kozakowski, Stefan Schaub, Philip F Halloran, Georg A Böhmig
Antibody-mediated rejection (ABMR) is a leading cause of graft failure. Emerging evidence suggests a significant contribution of natural killer (NK) cells to microvascular inflammation (MVI). We investigated the influence of genetically determined NK cell functionality on ABMR development and activity. The study included 86 kidney transplant recipients subjected to systematic biopsies triggered by donor-specific antibody detection. We performed killer immunoglobulin-like receptor typing to predict missing self and genotyped polymorphisms determining NK cell functionality (FCGR3AV/F158 [rs396991], KLRC2wt/del , KLRK1HNK/LNK [rs1049174], rs9916629-C/T)...
December 12, 2023: American Journal of Transplantation
https://read.qxmd.com/read/38090565/killer-instincts-natural-killer-cells-as-multifactorial-cancer-immunotherapy
#36
REVIEW
Sarah Nersesian, Emily B Carter, Stacey N Lee, Lauren P Westhaver, Jeanette E Boudreau
Natural killer (NK) cells integrate heterogeneous signals for activation and inhibition using germline-encoded receptors. These receptors are stochastically co-expressed, and their concurrent engagement and signaling can adjust the sensitivity of individual cells to putative targets. Against cancers, which mutate and evolve under therapeutic and immunologic pressure, the diversity for recognition provided by NK cells may be key to comprehensive cancer control. NK cells are already being trialled as adoptive cell therapy and targets for immunotherapeutic agents...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38077375/bw4-ligand-and-direct-t-cell-receptor-binding-induced-selection-on-hla-a-and-b-alleles
#37
JOURNAL ARTICLE
Reut Levi, Lee Levi, Yoram Louzoun
INTRODUCTION: The HLA region is the hallmark of balancing selection, argued to be driven by the pressure to present a wide variety of viral epitopes. As such selection on the peptide-binding positions has been proposed to drive HLA population genetics. MHC molecules also directly binds to the T-Cell Receptor and killer cell immunoglobulin-like receptors (KIR). METHODS: We here combine the HLA allele frequencies in over six-million Hematopoietic Stem Cells (HSC) donors with a novel machine-learning-based method to predict allele frequency...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38073888/genome-tuning-through-hla-and-kir-gene-clusters-impact-susceptibility-to-dengue
#38
REVIEW
Neha Sharma, Gaurav Sharma, Uma Kanga, Devinder Toor
Dengue is amongst the most prevalent viral diseases which globally affects millions of individuals annually and renders billions at risk, particularly in tropical and sub-tropical nations. WHO estimated 100-400 million infections each year and reported 4.2 million active cases in 2019 worldwide. The infection is caused by arthropod-transmitted dengue virus which is known to have 5 serotypes (DENV1-5). Most of the cases show mild clinical symptoms; though others may develop severe forms viz; dengue hemorrhagic fever and dengue shock syndrome...
September 2023: Infect Med (Beijing)
https://read.qxmd.com/read/38063382/six-years-of-disease-free-survival-after-a-second-cord-blood-transplantation-for-recurrent-acute-lymphocytic-leukemia-in-a-child-with-down-syndrome
#39
JOURNAL ARTICLE
Momoka Aoshima, Hiroshi Yagasaki, Katsuyoshi Shimozawa, Koji Kanezawa, Masaru Ueno, Ichiro Morioka
Outcomes are extremely poor in Down syndrome-associated acute lymphocytic leukemia, particularly in recurrent cases. A 2-year-old boy with Down syndrome-associated acute lymphocytic leukemia achieved complete remission after standard chemotherapy. However, he experienced recurrence twice in the bone marrow and central nervous system. Salvage treatments included whole-brain/whole-spine irradiation. Thereafter, the patient received a second cord blood transplantation after the reduced-intensity conditioning. The graft was characterized by killer cell immunoglobulin-like receptor ligands mismatch...
December 8, 2023: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38052043/systematic-evaluation-of-donor-kir-recipient-hla-interactions-in-hla-matched-hematopoietic-cell-transplantation-for-aml
#40
JOURNAL ARTICLE
Joshua Alexander Fein, Roni Shouval, Elizabeth Krieger, Stephen R Spellman, Tao Wang, Henning Baldauf, Katharina Fleischhauer, Nicolaus Kröger, Mary M Horowitz, Martin Maiers, Jeffrey S Miller, Mohamad Mohty, Arnon Nagler, Daniel J Weisdorf, Karl-Johan Malmberg, Amir Ahmed Toor, Johannes Schetelig, Rizwan Romee, John Koreth
In acute myeloid leukemia (AML), donor NK-cell killer immunoglobulin-like receptors (KIR) and recipient HLA interactions may contribute to the graft-versus-leukemia effect of allogeneic hematopoietic cell transplantation (HCT). Analyses of individual KIR/HLA interactions however have yielded conflicting findings, and their importance in the HLA-matched unrelated donor (MUD) setting remains controversial. We systematically studied outcomes of individual donor-KIR/recipient-HLA interactions for HCT outcomes and empirically evaluated prevalent KIR genotypes for clinical benefit...
December 5, 2023: Blood Advances
keyword
keyword
41013
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.